EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A 40-Year-Old Woman with Inoperable Uterine Fibroids Treated with Combined Uterine Artery Embolization and Relugolix

Livio Leo iD, Raphael Thomasset, Alessio Massaro iD, Raffaele Tinelli, Bianca Masturzo iD, Valentino Remorgida iD, Alessandro Libretti iD, Massimiliano Natrella iD

American Journal of Case Reports · 15.01.2025 · 26

DOI: 10.12659/ajcr.946334 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Case Reports, online erschienen am 15.01.2025. Verfasst von Livio Leo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Hopital Beauregard, AUSL Valleè d'Aoste, Aosta, Italy. Hauptthemen laut MEDLINE: Uterine Artery Embolization, Leiomyoma, Uterine Neoplasms, Hormone Antagonists. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Surgery was once considered the only possible treatment for uterine fibroids. However, a more conservative treatment approach can preserve women's reproductive capacity. In recent years, uterine artery embolization (UAE) and medical treatments have been introduced as a minimally or non-invasive therapeutic option. Relugolix is a non-peptide gonadotrophin-releasing hormone (GnRH) receptor antagonist used to reduce the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This report presents the case of a 40-year-old woman with inoperable uterine fibroids managed with combined uterine artery embolization and Relugolix, a non-peptide gonadotrophin-releasing hormone (GnRH) receptor antagonist. CASE REPORT A woman in her 40s presented with recurrent menometrorrhagia and an 80-mm uterine fibroid causing bleeding and anemia. Due to her medical history and previous surgeries, surgery was deemed risky. Instead, a conservative approach involving UAE followed by Relugolix combination therapy (Relugolix-CT) was pursued before performing minimally invasive surgery. Following bilateral UAE, the ultrasound scan showed there had already been a reduction in the fibroid size. Right after the UAE, the patient was discharged with Relugolix-CT, which reduced the symptoms and helped further reduce the fibroid's size and vascularity. Six months later, a mini-resectoscopic myomectomy was performed under local anaesthesia. CONCLUSIONS This case underscores the effectiveness of UAE and Relugolix-CT as a pre-surgical strategy for large uterine fibroids in patients who are not immediately suitable candidates for major surgery. This new combined approach can lead to improved patient outcomes and reduced surgical risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Artery EmbolizationLeiomyomaUterine NeoplasmsHormone AntagonistsHumansFemaleAdultGonadotropin-Releasing HormoneCombined Modality Therapy

Substanzen

Gonadotropin-Releasing HormoneHormone Antagonists

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Hopital Beauregard, AUSL Valleè d'Aoste, Aosta, Italy.
  • Department of Obstetrics and Gynecology SC1U, Città della Salute e della Scienza, Sant'Anna University Hospital, Turin, Italy.
  • Department of Obstetrics and Gynecology, Valle d'Itria Hospital, Martina Franca, Martina Franca, Italy.
  • Department of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", Biella, Italy.
  • Department of Gynecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
  • Department of Radiology, Hopital Parini, AUSL Valleè d'Aoste, Aosta, Italy.

ORCID-Profile: Livio Leo, Alessio Massaro, Bianca Masturzo, Valentino Remorgida, Alessandro Libretti, Massimiliano Natrella

Zitieren

APA

Leo, L., Thomasset, R., Massaro, A., Tinelli, R., Masturzo, B., Remorgida, V., Libretti, A., & Natrella, M. (2025). A 40-Year-Old Woman with Inoperable Uterine Fibroids Treated with Combined Uterine Artery Embolization and Relugolix. American Journal of Case Reports, 26. https://doi.org/10.12659/ajcr.946334

Vancouver

Leo L, Thomasset R, Massaro A, Tinelli R, Masturzo B, Remorgida V, et al. A 40-Year-Old Woman with Inoperable Uterine Fibroids Treated with Combined Uterine Artery Embolization and Relugolix. American Journal of Case Reports. 2025;26. doi:10.12659/ajcr.946334

BibTeX
@article{Leo2025,
  author = {Leo, Livio and Thomasset, Raphael and Massaro, Alessio and Tinelli, Raffaele and Masturzo, Bianca and Remorgida, Valentino and Libretti, Alessandro and Natrella, Massimiliano},
  title = {A 40-Year-Old Woman with Inoperable Uterine Fibroids Treated with Combined Uterine Artery Embolization and Relugolix},
  journal = {American Journal of Case Reports},
  year = {2025},
  volume = {26},
  doi = {10.12659/ajcr.946334}
}
Kostenlos starten →